PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-60979 Oracle Corporation CVE debrief

AI-assisted PatchSiren debrief based on the supplied source corpus. The CVE record was published on 2026-07-21T22:18:31.217Z and has not been modified since then. This high-severity vulnerability affects Oracle Scripting product versions 12.2.3-12.2.15, allowing unauthenticated network attackers to potentially takeover the product. Evidence is limited to CVE and NVD details. Defenders should verify affected product deployments and review vendor guidance for patching and mitigation. The vulnerability has a CVSS 3.1 score of 8.1, indicating high severity for confidentiality, integrity, and availability impacts.

Vendor
Oracle Corporation
Product
Oracle Scripting
CVSS
HIGH 8.1
CISA KEV
Not listed in stored evidence
Original CVE published
2026-07-21
Original CVE updated
2026-07-31
Advisory published
2026-07-21
Advisory updated
2026-07-31

Who should care

Oracle E-Business Suite users, Security teams, IT administrators, and operators managing Oracle Scripting product deployments should review and address this vulnerability. Vulnerability management and security teams should prioritize patching based on CVSS severity and potential impact on confidentiality, integrity, and availability.

Technical summary

CVE-2026-60979 is a high-severity vulnerability in Oracle Scripting product versions 12.2.3-12.2.15. The vulnerability allows unauthenticated attackers with network access via HTTP to compromise Oracle Scripting, potentially leading to product takeover. Successful attacks can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). The vulnerability is difficult to exploit and requires network access via HTTP. Oracle E-Business Suite users, Security teams, IT administrators, and operators managing Oracle Scripting product deployments should review and address this vulnerability.

Defensive priority

Oracle Scripting vulnerability allows unauthenticated network attackers to potentially takeover the product; apply vendor patches immediately.

Recommended defensive actions

  • Apply Oracle patches for CVE-2026-60979
  • Restrict network access to Oracle Scripting
  • Monitor Oracle Scripting logs for suspicious activity
  • Review compensating controls for exposed systems while remediation is scheduled and verified
  • Check relevant monitoring, detection, and logs for exposed assets that need extra review
  • Track exceptions, retest remediated assets, and close the item only after evidence is documented
  • Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The CVE-2026-60979 vulnerability affects Oracle Scripting product versions 12.2.3-12.2.15. CVSS 3.1 score of 8.1 indicates high severity. Evidence is limited to CVE and NVD details. Defenders should verify affected product deployments and review vendor guidance for patching and mitigation. No additional information is available on exploitation or affected scope beyond vendor reports.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-60979 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-60979

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-60979 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-60979

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.